A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound
ConditionHeart Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorMayo Clinic
About this trial
A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
Eligibility criteria
Qualifiers
Enrollment in a high-school, college or a resident in MN during the study period
Age 15-29 years
Informed consent (and assent for minors)
Disqualifiers
Presence of a pacemaker or defibrillator
Inability to obtain a quality ECG tracing
Adult female aged 18 to 49 years
Pregnant at the time of enrollment
Trial design
Treatments tested in this trial
- Focused Cardiac Ultrasound
- 6-Lead AI-ECG
- 12-Lead AI-ECG
Treatment groups
19,300 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov